Table 3.

Multivariate analysis

nOR or RR*Lower CLUpper CLPOverall P
Acute grade 2-4 GVHD
 Haploidentical donors1231.009
 MSD4930.880.581.33.54
 MUD TCD+3770.920.601.41.70
 MUD TCD−3591.390.902.13.13
Acute grade 3-4 GVHD
 Haploidentical donors1231.0007
 MSD4931.560.753.26.24
 MUD TCD+3771.840.883.89.11
 MUD TCD−3593.051.476.32.0028
Chronic GVHD
 Haploidentical donors1271<.0001
 MSD4693.152.084.77<.0001
 MUD TCD+3212.051.323.17.001
 MUD TCD−3444.062.686.15<.0001
NRM
 Haploidentical donors1321.08
 MSD5220.900.601.360.62
 MUD TCD+4031.170.771.760.46
 MUD TCD−3781.280.861.910.23
Significant contrast
 MSD vs MUD TCD−0.710.540.93.01
Relapse/progression
 Haploidentical donors1321.009
 MSD5251.060.791.41.71
 MUD TCD+4030.920.681.25.60
 MUD TCD−3780.730.531.00.05
Significant contrast
 MSD vs MUD TCD−1.451.171.80.0008
PFS
 Haploidentical donors1321.45
 MSD5220.940.741.19.61
 MUD TCD+4030.970.761.24.84
 MUD TCD−3780.860.671.09.21
OS
 Haploidentical donors1321.52
 MSD5220.900.691.16.42
 MUD TCD+4031.020.781.33.90
 MUD TCD−3780.910.701.19.49
  • The main effect of multivariate analysis is shown. Complete multivariate analysis results are provided in supplemental Table 3.

  • CL, confidence limit.

  • * Values are odds ratios (ORs) for “Acute grade 2-4 GVHD” and “Acute grade 3-4 GVHD”; all others are RR.